Advertisement
Increasing patients' physical activity is an effective strategy to lower future risk of heart failure

Starting Exercise Even in Older Age Cuts Heart Failure Risk

0
Benefit seen from approximately 30 minutes of brisk walking four times per week
Recipients of the herpes zoster subunit vaccine

Robust Immune Responses for Herpes Zoster Subunit Vaccine

0
Humoral response seen for 97.8 percent of HZ/su vaccine recipients versus 2 percent of placebo
Many women report dysfunctional toileting behaviors

AUA: Most Women Report Dysfunctional Toileting Behaviors

0
Large proportions of women report premature voiding, straining to void, and delayed voiding
The risk of dementia is increased for adults in the lowest versus the highest wealth quintile

Risk of Dementia Up for Older Adults With Lowest Wealth

0
Increased risk seen independent of education, index of multiple deprivation, health indicators
Aimovig (erenumab-aooe) has been approved by the U.S. Food and Drug Administration to prevent migraine headaches in adults.

FDA Approves Aimovig to Prevent Migraines

0
Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo
Patterns of potential opioid misuse are positively associated with subsequent opioid overdose

Patterns of Potential Misuse Help Assess Risk of Opioid Overdose

0
Positive link for subsequent opioid overdose with greater numbers of prescribers and pharmacies
Anthocyanin intake is associated with slower decline in lung function

Slower Decline in Lung Function With Anthocyanin Intake

0
Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake
Semaglutide is safe and effective for the treatment of type 2 diabetes

Semaglutide Found to Be Effective Against Type 2 Diabetes

0
The once-weekly glucagon-like peptide 1 receptor agonist cuts HbA1c, body weight
For patients with active cancer and venous thromboembolism (VTE)

Rivaroxaban Linked to Low VTE Recurrence in Active Cancer

0
Lower rate of VTE recurrence, but higher clinically relevant non-major bleeding versus dalteparin
Risk-standardized mortality rates for ischemic heart disease and chronic heart failure vary across Veterans Affairs Medical Centers

Ischemic Heart Disease, CHF Mortality Vary Across VA Systems

0
Risk-standardized mortality rates vary considerably across Veterans Affairs Medical Centers